A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

Recruiting

• Conditions: Non Small Cell Lung Cancer
• Interventions: Device: Wearable smart devices and PROs

• Registration Number: NCT06118229
• Lead Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Brief Summary

The trial was designed as a single-center non-interventional prospective observational study to explore the role and impact of wearable smart devices in perioperative NSCLC patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-09
• Study First Submitted: 2023-10-27
• Study First Submitted QC: 2023-11-03
• Study First Posted: 2023-11-07
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-26
• Last Update Posted: 2024-06-28
• Primary Completion: 2024-07-31
• Study Completion: 2026-03-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form.
2. Participants must be aged over 18 years.
3. Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer.

Exclusion Criteria

1. Patient refusal to participate in this research.
2. Inability to wear wearable smart monitoring devices due to various reasons.
3. The pathological report suggests a non-small cell lung cancer (NSCLC) exclusion.
4. History of secondary lung cancer surgery.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
NSCLC patients wearing wearable smart devices	Wearable smart devices and PROs	NSCLC patients wearing wearable smart devices while utilizing PROs for regular follow-up

Primary Outcome Measures

Name	Time	Method
Postoperative length of hospital stay	From time of surgery to time of discharge from the hospital (assessed up to 30 days)	Postoperative Length of Stay (LOS) refers to the duration of a patient's hospitalization following surgery, typically measured from the completion of the surgical procedure to the time of patient discharge.

Secondary Outcome Measures

Name	Time	Method
Operative time	From time of the start of surgery to the end of surgery	Operative time is defined as the time from the start of the surgical procedure to its completion, including anesthesia induction, surgical incision, manipulation of tissues, closure, and completion of all surgical tasks.

Trial Locations

Locations (1)

Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University; 🇨🇳 Guangzhou, Guangdong, China